본문 바로가기
KERD
논문KCI 등재

Expression of Cyclooxygenase-2 and its Relationship to p53 Accumulation in Colorectal Cancers

민영돈|김경종|이태범|최철희|유소연|임승철
연세대학교의과대학 (Yonsei University College of Medicine)|2007.06|Yonsei Medical Journal|제48권 제3호|pp. 495-501

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류의학일반

초록

Abstract

Purpose: Cyclooxygenase (COX)-2 is an inducible isoform responsive to cytokines, mitogens, and growth factors, and is believed to be an important enzyme related to colorectal cancer (CRC). Existing evidence suggests that COX-2 expression is normally suppressed by wild-type p53 but not mutant p53, suggesting that loss of p53 function may result in the induction of COX-2 expression. The aim of this study was to determine the relationship between COX-2 expression and p53 levels in CRC. Materials and Methods: Patients with sporadic colorectal adenocarcinoma (n=161) who underwent curative surgery in Chosun University Hospital were enrolled in this study. Expression of COX-2 and p53 proteins was examined by immunohistochemistry in paraffin-embedded cancer tissue blocks, and the relationship between COX-2 and/or p53 expression with clinicopathologic parameters was analyzed. Results: Expression of COX- 2 was positive in 47.8% of colorectal cancers, and significantly associated with the depth of tumor invasion (p= 0.042). In contrast, p53 was positive in 50.3% of the cases, and was associated with both age (p=0.025) and the depth of tumor invasion (p=0.014). There was no correlation between COX-2 expression and p53 expression (p=0.118). Conclusion: These results suggest that COX-2 expression might play an important role in the progression of colorectal cancer. However, COX-2 expression was not associated with mutational p53. Further studies are needed to clarify the regulatory mechanisms governing COX-2 overexpression in colorectal cancers.

참고문헌 (22)

  1. "Smans M", int j cancer 1985, pp.36~
  2. "Ministry of Health and Welfare Republic of Korea" (2002)
  3. "Vogelstein B", cell 1990, pp.61~
  4. "The role of cyclooxygenases in inflammation, cancer, and development", 18, pp.7908~7916 (1999)
  5. "a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells", pp.12866~72
  6. "Cyclooxygenase2: a molecular target for cancer prevention and treatment", 24, pp.96~102 (2003)
  7. "Inhibition of cyclooxygenase-2 gene expression by p53", 274, pp.10911~10915 (1999)
  8. "Recommendation for uniform definition of an immunoreactive score", pp.138~40
  9. "Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer", 45, pp.98~103 (2002)
  10. "Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance", 11, pp.1105~1108 (2005)
  11. "Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer", 10, pp.8465~8471 (2004)
  12. "Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer", 19, pp.527~534 (2002)
  13. "Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients", 6, pp.4064~4068 (2000)
  14. "Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis, of colorectal cancer", 83, pp.324~328 (2000)
  15. "Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT- 0089", 21, pp.2912~2919 (2003)
  16. "Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis", 49, pp.392~398 (2006)
  17. "Multiple roles of the tumor suppressor p53", 14, pp.86~91 (2002)
  18. "Finlay CA", nature 1991, pp.351~
  19. "Hollstein M", n engl j med 1993, pp.329~
  20. "Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression", 233, pp.232~239 (2006)
  21. "Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer", 34, pp.189~194 (1999)
  22. "Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer", 91, pp.355~361 (2004)

관련 논문AI추천

Clinical Value of Cyclooxygenase-2 Expression in Human Breast CarcinomaGyung-Yub Gong, Jin-Hee Ahn, Jung-Shin Lee, Myung-Ju Ahn, Sei-Hyun Ahn, Sung-Bae Kim, Woo Kun Kim, Yoon-Koo Kang대한암학회 · Cancer Research and Treatment2004 · 제36권 제3호Correlation Between p53 and p21 Proteins Expression and Prognostic Factors Related with Colon Cancer김태근, 김태전대한임상검사과학회 · 대한임상검사과학회지2007 · 제39권 제2호Cyclooxygenase-2: A Potential Target in Human CancerJong-Ho Won대한암학회 · Cancer Research and Treatment2004 · 제36권 제3호Expression of Cyclooxygenase-2 and Tumor Microvessel Density in Colorectal Cancer손진희, 이봉화, 채승완, Eo Jin Kim, Eun Yoon Cho대한암학회 · Cancer Research and Treatment2003 · 제35권 제5호Thymidylate Synthase, Thymidine Phosphorylase, VEGF and p53 Protein Expression in Primary Colorectal Cancer for Predicting Response to 5-fluorouracil-based ChemotherapyChan-Kum Park, Ho-Suk Oh, Il-Young Choi, In-Soon Kim, Jung-Hye Choi, Kang-Hong Lee, Kang-Won Song, Myung-Ju Ahn, Young-Yeul Lee대한암학회 · Cancer Research and Treatment2005 · 제37권 제4호Expression of Cyclooxygenase (COX)-2 as a Prognostic Factor in Nasopharyngeal CancerCharn Il Park, Chong Jai Kim, Hong-Gyun Wu, Kyubo Kim, Suk Won Park대한암학회 · Cancer Research and Treatment2004 · 제36권 제3호

이 간행물의 다른 논문 (17건)

Current Issues on Molecular and Immunological Diagnosis of Tuberculosis조상래pp. 347-359Positive-Thinking and Life Satisfaction amongst Koreans오윤희, 정지영, 신영철, 김현정, 오강섭, 서동우pp. 371-378Salivary Cortisol and DHEA Levels in the Korean Population: Age-Related Differences, Diurnal Rhythm, and Correlations with Serum Levels권혁방, 이영진, 최준영, 안련섭, 전세일pp. 379-388Endothelial Nitric Oxide Synthase Glu298Asp Gene Polymorphism is Associated with Hypertensive Response to Exercise in Well-Controlled Hypertensive Patients고영국, 김중선, 임세중, 조정래, 정남식, 박성하, 하종원, 심재민, 장양수, 김진배, 최동훈, 조덕규, 신현준, 박찬미pp. 389-395Vaccination against Murine Toxoplasmosis Using Recombinant Toxoplasma gondii SAG3 Antigen Alone or in Combination with Quil A이재호, 신대완, 이영하, 안명희, 남호우pp. 396-404
원문 보기